AURO-MONTELUKAST CHEWABLE TABLET

Identification of Auro-Montelukast Chewable Tablet

No description

Google image searchProduct monograph

Active ingredient

montelukast (montelukast sodium), 5 MG

DIN: 02422875

Dosage form(s): TABLET (CHEWABLE)

Route(s) of administration: ORAL

Schedule: Prescription

Company: AURO PHARMA INC

Date: 10-MAY-2022

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD)
• R03DC — Leukotriene receptor antagonists (ATC, ATC/DDD)
• R03DC03 — MONTELUKAST (ATC/DDD)

Reference brand drug: Singulair

Pharmaceutical standard: MFR

External Links for Auro-Montelukast Chewable Tablet

Search on Google

• Auro-Montelukast Chewable Tablet side effects
• Auro-Montelukast Chewable Tablet dosage
• montelukast side effects
• montelukast dosage

Auro Pharma Inc

Go to Auro Pharma website to see drug product details. Sometimes you can find auro-montelukast chewable tablet photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.